Cardiovascular adverse events in patients with non-Hodgkin lymphoma treated with first-line cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or CHOP with rituximab (R-CHOP): a systematic review and meta-analysis
Titel:
Cardiovascular adverse events in patients with non-Hodgkin lymphoma treated with first-line cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or CHOP with rituximab (R-CHOP): a systematic review and meta-analysis
Auteur:
Linschoten, Marijke Kamphuis, Janine A M van Rhenen, Anna Bosman, Laurens P Cramer, Maarten J Doevendans, Pieter A Teske, Arco J Asselbergs, Folkert W